Medical Marijuana (MJNA) Stock Price, News & Analysis

Company Overview

Medical Marijuana, Inc. is an early pioneer in the cannabis and hemp industry, specializing in investments and operations across the hemp-derived cannabinoid marketplace. The company focuses on sourcing high-quality industrial hemp, extracting bioactive compounds such as cannabidiol (CBD), and bringing branded wellness products to market. Through strategic equity positions and subsidiary management, Medical Marijuana, Inc. seeks to advance research, production and distribution capabilities in the rapidly evolving cannabinoid sector.

The company’s key business activities are organized through several core subsidiaries and brands. HempMeds PX is its principal U.S. distribution arm, offering Real Scientific Hemp Oil (RSHO) and nano-amplified formulations designed to enhance CBD bioavailability. Kannaway operates as a global network-marketing channel, providing a range of hemp oil-based tinctures, capsules and topicals. In addition, Medical Marijuana, Inc. collaborates with manufacturing partners to develop pet-focused CBD products and to explore novel delivery systems for human wellness applications.

Medical Marijuana, Inc. maintains a presence in North America, Europe and Latin America, supplying products to regulated markets such as Germany, the United Kingdom, Brazil, Uruguay and Chile. Its subsidiaries adhere to region-specific compliance standards for cultivation, extraction and distribution, while forging research partnerships with academic and clinical laboratories. These initiatives aim to substantiate the safety and efficacy of hemp-derived cannabinoids and to expand consumer access through emerging regulatory frameworks.

Originally founded in 2009 and headquartered in San Diego, California, Medical Marijuana, Inc. has grown through both organic development and targeted acquisitions. Dr. Stuart Titus has served as chief executive officer since 2014, overseeing corporate strategy, subsidiary operations and investor relations. Under his leadership, the company has positioned itself as a vertically integrated participant in the hemp-cannabinoid value chain, with a focus on product innovation, global market expansion and scientific validation of therapeutic potential.

Key Stats

• Today's Range: $0.0001 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0004
• Volume: 21.54 million shs
• Average Volume: 21.25 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Medical Marijuana Stock Analysis - MarketRank™

Medical Marijuana scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Medical Marijuana.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Medical Marijuana is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medical Marijuana is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Medical Marijuana has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medical Marijuana has recently increased by 100.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medical Marijuana does not currently pay a dividend.

Dividend Growth

Medical Marijuana does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

5 people have added Medical Marijuana to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medical Marijuana insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.03% of the stock of Medical Marijuana is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:MJNA
• CIK: N/A
• Web: www.medicalmarijuanainc.com
• Phone: (866) 273-8502
• Fax: N/A
• Employees: 91
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A